4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-23-006452
Options or other derivatives
- CMO acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Donovan Joanne M. · CMO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +200,000 | 200,000 | D |
Loading xslF345X05/primarydocument.xml…